表3
汇总结果显示未调整,调整后的平均医疗支出所有的测试(2013美元)。
测试
未经调整的平均医疗支出
调整后的平均医疗支出
CMS
相对区别CMS
TB-specific测试
86481 (T-SPOT。结核病(T-Spot))
140.77 (104.52)
105.81 (103.72 - -107.94)
102.99
2.7%
87556(友人;结核分枝杆菌 )
123.34 (141.54)
74.45 (68.53 - -80.87)
48.24
54.3%
87557 (NAQ;结核分枝杆菌 )
77.53 (25.84)
73.1 (68.09 - -78.47)
58.88
24.1%
86480 (QuantiFERON-TB黄金管[QFT-GIT])
86.96 (88.08)
69.14 (68.83 - -69.46)
85.20
−18.8%
87555(辅酶ii;结核分枝杆菌 )
73.77 (75.4)
45.78 (37.51 - -55.88)
27.57
66.1%
86580(结核菌素皮肤试验(TST))
10.52 (26.59)
8.68 (8.67 - -8.69)
8.64
0.4%
非特异性结核病测试
71260(胸部电脑断层摄影术)
454.23 (573.78)
251.11 (250.33 - -251.89)
266.40
−5.7%
87153(文化、打字;NA序列,每个隔离)
193.31 (149.87)
145.08 (135.66 - -155.15)
158.57
−8.5%
87150(文化、打字;友人,每个组织。探索)
275.85 (396.52)
135.04 (-140 - 130.26)
48.24
179.9%
87552 (NAQ;分枝杆菌物种)
127.85 (88.91)
92.66 (52.48 - -163.61)
58.88
57.4%
87799 (NAQ号;每个有机体)
122.78 (307.61)
78.86 (78.36 - -79.36)
58.88
33.9%
87550(辅酶ii;分枝杆菌物种)
84.55 (85.42)
60.42 (45.03 - -81.07)
27.57
119.1%
友人87798号;每个有机体)
78.58 (138.91)
47.54 (47.44 - -47.63)
48.24
−1.4%
87551(友人;分枝杆菌物种)
84.12 (221.03)
45.89 (41.94 - -50.21)
48.28
−5.0%
87188(易感性的研究;macrobroth稀释)
125.81 (207.41)
39.65 (35.72 - -44.01)
9.12
334.7%
71020(胸片;2视图)
63.39 (101.58)
38.16 (38.13 - -38.2)
30.96
23.3%
87143(文化、打字;、相关/高效液相色谱法)
60.96 (61.75)
37.08 (32.77 - -41.96)
17.22
115.3%
87116(文化、结节/其他抗酸的细菌)
57.36 (91.95)
31.32 (30.94 - -31.71)
14.85
110.9%
87190(易感性的研究;分枝杆菌)
51.69 (70.78)
24.8 (18.56 - -33.13)
7.77
219.1%
87118(文化、分枝杆菌、每个隔离)
37.62 (50.52)
20.35 (19.38 - -21.37)
15.04
35.3%
87149(文化、打字;辅酶ii,每个组织。探索)
25.35 (75.55)
18.51 (18.44 - -18.57)
27.57
−32.9%
87206(涂片镜检)
25 [52.12]
12.69 (12.58 - -12.8)
7.39
72.4%
87158(文化、打字;其他方法)
14.53 (28.34)
9.08 (8.7 - -9.48)
7.19
26.3%
安排在减少数量级。重要性级别:
,
高于下一个估计。CMS,医疗保险和医疗补助服务中心;SD,标准偏差;结核、结核;NAAP核酸扩增探测器;辅酶ii,核酸直接探测;NAQ核酸量化;NA,核酸;号,而不是另有规定;相关,气液色谱法; HPLC, high pressure liquid chromatography. The brand names for the respective IGRA testing method CPT codes (i.e., QuantiFERON-TB Gold In-Tube [QFT-GIT] for 86480 and T-SPOT.TB [T-Spot] for 86481) were used because they were the only IGRA tests approved by the Food and Drug Administration (FDA) as of 2013 [7 ]。
